Found 100 matching trials
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer PHASE1 To evaluate the tolerability and safety of combination of ONO-4578 and ONO-...
Show More Status
Active Not Recruiting
Location
National Cancer Center Hospital East
Learn More & Join Trial
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma PHASE2 Purpose of the Study:
This clinical study investigates whether a shorter o...
Show More Location
Amsterdam University Medical Center
Learn More & Join Trial
The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer PHASE1 To confirm the tolerability and safety of combined administration of ONO-79...
Show More Status
Active Not Recruiting
Location
Fujita Health University Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy PHASE1 This is an open-label, single-arm, single-center Phase Ib/II study to explo...
Show More Location
National Cancer Center Hospital East
Learn More & Join Trial
A Benefit Population Atlas of nICT Versus nCT for LAGC N/A The purpose of this observational study is to evaluate the impact of differ...
Show More Location
Jiangsu Cancer Hospital
Learn More & Join Trial
FOG-001 in Locally Advanced or Metastatic Solid Tumors PHASE1 The goal of this clinical trial is to determine if FOG-001 is safe and effe...
Show More Learn More & Join Trial
Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma N/A The goal of the study is to learn about Safety and efficacy of preoperative...
Show More Learn More & Join Trial
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma PHASE2 This is an open label, phase II, multi-site trial evaluating the efficacy a...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction PHASE3 Previously untreated patients with limited metastatic stage (see protocol f...
Show More Location
Krankenhaus Nordwest
Learn More & Join Trial